Skip to search formSkip to main contentSkip to account menu

TMC 278

Known as: 278, TMC, TMC-278, TMC278 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
ABSTRACT Rilpivirine (TMC278) is a highly potent nonnucleoside reverse transcriptase inhibitor (NNRTI) representing an effective… 
2015
2015
Cationic polymers have recently attracted attention due to their proven potential for nonviral gene delivery. In this study, we… 
2012
2012
The aim of the present study was to investigate the effects of varying degrees of quaternization (DQ: 22, 35 and 41%) on the… 
2011
2011
Lost to follow-up, non-compliance, withdrew consent, ineligible to continue, sponsor's decision • Similar response rates for RPV… 
2010
Review
2009
Review
2009
The recent availability of new antiretroviral agents for the treatment of human immunodeficiency virus (HIV) infection has… 
1996
1996
AbstractPurpose. The described structure pharmacokinetic pharmacodynamic relationships (SPPR) study explored the utilization of…